Drug Discovery Journals

A review and news journal covering the full drug discovery pipeline from target identification and validation through preclinical and clinical development. Publishes authoritative reviews on AI in drug discovery, high-throughput screening technologies, biomarker-driven approaches, drug repurposing, and emerging translational research strategies.

An expert review journal offering in-depth evaluation of cutting-edge drug discovery science from early target identification through to lead optimization. Covers emerging drug targets, novel screening methodologies, cheminformatics approaches, translational technologies, and pharmaceutical investment trends with expert assessment of discovery strategies.

Publishes papers on all aspects of drug discovery and development, from molecular target identification through preclinical evaluation. Coverage includes medicinal chemistry, structural biology, in silico drug design, pharmacology and toxicology, lead optimization, formulation, and preclinical pharmacokinetics. Particularly welcoming of work bridging chemistry, biology and translational pharmaceutics.

Publishes research on all aspects of chemical biology relevant to high-throughput screening and combinatorial chemistry in drug discovery, including assay development, target-based and phenotypic screening, biomarkers, ADMET screening, compound management, chemo/bio-informatics, natural products research, and drug repurposing strategies.